Inventor · disambiguated record
Ron Schlinger
Also filed as: SCHLINGER RON
11 granted patents·10 pending applications·8 citations·filing 2008–2023
82Inventor score
Top patents by PatentIndex Score
21 records- 0192US10548837B1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2017·Granted Feb 4, 2020·7 cites·7 claims
- 0275US2023248641A1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2023·Application pending·0 cites
- 0370US11844861B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 0470US10774176B2Alternating and semi-alternating poly(ester-anhydride) copolymersDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2015·Granted Sep 15, 2020·1 cites·19 claims
- 0567US2023293543A1Fenoldopam topical formulations for treating skin disordersTARO PHARMA IND·Filed 2023·Application pending·0 cites
- 0665US11173117B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Nov 16, 2021·0 cites·27 claims
- 0765US2023172960A1Topical capecitabine for the treatment of hyperproliferative skin conditionsTARO PHARMA IND·Filed 2022·Application pending·0 cites
- 0863US11612607B2Fenoldopam topical formulations for treating skin disordersTARO PHARMA IND·Filed 2017·Granted Mar 28, 2023·0 cites·7 claims
- 0963US11559541B2Topical capecitabine for the treatment of hyperproliferative skin conditionsTARO PHARMA IND·Filed 2019·Granted Jan 24, 2023·0 cites·13 claims
- 1063US2023059107A1Stable topical compositions of fenoldopamTARO PHARMA IND·Filed 2022·Application pending·0 cites
- 1161US2020237651A1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2020·Application pending·0 cites
- 1260US11299583B2Alternating and semi-alternating poly(ester-anhydride) copolymersDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2020·Granted Apr 12, 2022·0 cites·19 claims
- 1360US2023414537A1Topical naftifine compositionsTARO PHARMA IND·Filed 2023·Application pending·0 cites
- 1458US11446237B2Stable topical compositions of fenoldopamTARO PHARMA IND·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 1556US12233055B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Feb 25, 2025·0 cites·11 claims
- 1656US2011052648A1Oral modified-release formulations containing thiazepinesAVRAMOFF AVI·Filed 2009·Application pending·0 cites
- 1752US2023057282A1Compositions comprising desoximetasone and tazaroteneTARO PHARMA IND·Filed 2020·Application pending·0 cites
- 1852US2019125792A1Pharmaceutical compositions comprising ferric citrate and methods for the production thereofDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2019·Application pending·0 cites
- 1947US10172882B2Pharmaceutical compositions comprising ferric citrate and methods for the production thereofDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2015·Granted Jan 8, 2019·0 cites·24 claims
- 2046US2010278909A1Process for forming solid oral dosage forms of angiotensin ii receptor antagonistsDEXCEL LTD·Filed 2008·Application pending·0 cites
- 2144US11141488B2Compositions comprising biodegradable copolymers for prolonged local release of an antibioticDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2017·Granted Oct 12, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Ron Schlinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →